Europe · Markets & Finance · L'Agefi

Lonza séduit le marché par ses perspectives de moyen terme

Published by L'Agefi · France 1 d ago

Le fabricant suisse de médicaments vise une marge d’Ebitda autour de 38% à moyen terme, contre 33% à 34% attendu cette année. Le chiffre d’affaires devrait croître de 10% à 13%…

Read the full article on L'Agefi Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.agefi.fr)

Also worth reading

Financial Times

Dollar weakens as Fed’s Warsh declines to hint at October rate rise

City A.M.

New inheritance tax rules will drastically change pension use

This is Money

UK falls to 24th spot in the world's best countries to start a business: We reveal the full top 50

Reuters Markets

Dollar retreats from 18-month high as Treasury yields dip; Fed hike bets ease

Reuters Sustainability

Tech stocks tumble as data centre debt worries hit AI trades

Investors Chronicle